Search Results - "Marnell, Christopher S."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease by Marnell, Christopher S., Bick, Alexander, Natarajan, Pradeep

    “…Clonal hematopoiesis of indeterminate potential (CHIP) is the presence of a clonally expanded hematopoietic stem cell caused by a leukemogenic mutation in…”
    Get full text
    Journal Article
  2. 2

    B7–H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors by Maachani, Uday B., Tosi, Umberto, Pisapia, David J., Mukherjee, Sushmita, Marnell, Christopher S., Voronina, Julia, Martinez, Daniel, Santi, Mariarita, Dahmane, Nadia, Zhou, Zhiping, Hawkins, Cynthia, Souweidane, Mark M.

    Published in Translational oncology (01-02-2020)
    “…B7–H3 (CD276), a member of the B7 superfamily, is an important factor in downregulating immune responses against tumors. It is also aberrantly expressed in…”
    Get full text
    Journal Article
  3. 3

    Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors by Tosi, Umberto, Marnell, Christopher S, Chang, Raymond, Cho, William C, Ting, Richard, Maachani, Uday B, Souweidane, Mark M

    “…Thanks to the recent advances in the development of chemotherapeutics, the morbidity and mortality of many cancers has decreased significantly. However,…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    18 F-Radiolabeled Panobinostat Allows for Positron Emission Tomography Guided Delivery of a Histone Deacetylase Inhibitor by Kommidi, Harikrishna, Tosi, Umberto, Maachani, Uday B, Guo, Hua, Marnell, Christopher S, Law, Benedict, Souweidane, Mark M, Ting, Richard

    Published in ACS medicinal chemistry letters (08-02-2018)
    “…Histone deacetylase (HDAC) inhibition is becoming an increasingly popular approach to treat cancer, as HDAC overexpression is common in many malignancies. The…”
    Get full text
    Journal Article
  7. 7

    18F‑Radiolabeled Panobinostat Allows for Positron Emission Tomography Guided Delivery of a Histone Deacetylase Inhibitor by Kommidi, Harikrishna, Tosi, Umberto, Maachani, Uday B, Guo, Hua, Marnell, Christopher S, Law, Benedict, Souweidane, Mark M, Ting, Richard

    Published in ACS medicinal chemistry letters (08-02-2018)
    “…Histone deacetylase (HDAC) inhibition is becoming an increasingly popular approach to treat cancer, as HDAC overexpression is common in many malignancies. The…”
    Get full text
    Journal Article
  8. 8

    Abstract 11843: Population Effects of Clinical, Laboratory, and Genetic Risk Factors for Incident CAD: A Cohort Study in the UK Biobank by Marnell, Christopher S, Bhattacharya, Romit, Zekevat, Seyedeh M, Trinder, Mark, Honigberg, Michael, Peloso, Gina, Natarajan, Pradeep

    Published in Circulation (New York, N.Y.) (16-11-2021)
    “…BackgroundModifiable clinical risk factors are estimated to account for the majority of population attributable risk (PAR) for first myocardial infarction…”
    Get full text
    Journal Article